Cognitive behavioral therapy versus paroxetine in the treatment of hypochondriasis: An 18-month naturalistic follow-up

Journal of Behavior Therapy and Experimental Psychiatry

Volumn 40, Issue 3, 2009, Pages 487-496

  Greeven, Anja ^a,d   van Balkom, Anton J L M ^b   van der Leeden, Rien ^a   Merkelbach, Jille W ^c   van den Heuvel, Odile A ^b   Spinhoven, Philip ^a,c  

^a LEIDEN UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d PsyQ ^*  (Netherlands)

Author keywords

Cognitive behavioral therapy; Follow up; Hypochondriasis; Paroxetine; Whiteley Index

Indexed keywords

PAROXETINE;

ADULT; ANXIETY DISORDER; ARTICLE; COGNITIVE THERAPY; COMORBIDITY; COMPARATIVE STUDY; DEPRESSION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; HYPOCHONDRIASIS; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME; WHITELEY INDEX;

ADULT; CHI-SQUARE DISTRIBUTION; COGNITIVE THERAPY; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOCHONDRIASIS; MALE; MIDDLE AGED; PAROXETINE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 68949184828     PISSN: 00057916     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbtep.2009.06.005     Document Type: Article

References (24)

1. Arrindell W.A., and Ettema J.H.M. Handleiding bij en multidimensionele psychopathologie indicator (1986), Lisse Swets & Zeitlinger
2. Barsky A.J., and Ahern D.K. Cognitive behavior therapy for hypochondriasis: a randomized controlled trial. JAMA: The Journal of the American Medical Association 291 12 (2004) 1464-1470
3. Barsky A.J., Klerman G.L., Cleary P.D., and Sarnie M.K. The course of transient hypochondriasis. American Journal of Psychiatry 150 3 (1993) 484-488
4. Clark D.M., Salkovskis P.M., Hackmann A., Wells A., Fennell M., Ludgate J., et al. Two psychological treatments for hypochondriasis. A randomised controlled trial. British Journal of Psychiatry 173 (1998) 218-225
5. Fallon B.A., Liebowitz M.R., Salman E., Schneier F.R., Jusino C., Hollander E., et al. Fluoxetine for hypochondriacal patients without major depression. Journal of Clinical Psychopharmacology 13 6 (1993) 438-441
6. Fallon B.A., Petova E., Skritskaya N., Sacnhez-Lacay A., Schneier F., Vermes D., et al. A double-masked, placebo-controlled study of fluoxetine for hypochondriasis. Journal of Clinical Psychopharmacology 28 6 (2008) 638-645
7. Fallon B.A., Schneier F.R., Marshall R., Campeas R., Vermes D., Goetz D., et al. The pharmacotherapy of hypochondriasis. Psychopharmacology Bulletin 32 4 (1996) 607-611
8. Fava G.A., Savron G., Saviotti F.M., Raffi A.R., Grandi S., Belluardo P., et al. Benzodiazepines and anxiety sensitivity in panic disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 18 7 (1994) 1163-1168
9. First M.B., Spitzer R.L., Gibbon M., and Williams J.B. Structured clinical interview for DSM-IV Axis I disorders (1996), New York State Psychiatric Institute, New York
10. Goekoop J.G., Knoppert-Van-der-Klein E.A., Hoeksema T., and Klinkhamer R.A. The interrater reliability of a Dutch version of the comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica 83 (1991) 202-205
11. Goekoop J.G., Knoppert-Van-der-Klein E.A., Hoeksema T., and Zwinderman A.H. Onderzoek met de CPRS in Nederlandse vertaling. Betrouwbaarheid, factorstructuur en intensiteitsbeoordeling (The Dutch version of the comprehensive psychopathology rating scale: reliability, factor structure, and intensity rating scales). Tijdschrift voor Psychiatrie 36 7 (1994) 520-526
12. Greeven A., van Balkom A.J.L.M., Visser S., Merkelbach J.W., van Rood Y.R., van Dyck R., et al. Cognitive behavior therapy and paroxetine in the treatment of hypochondriasis: a randomized controlled trial. American Journal of Psychiatry 164 1 (2007) 91-99
13. Hiller W., Leibbrand R., Rief W., and Fichter M.M. Predictors of course and outcome in hypochondriasis after cognitive-behavioral treatment. Psychotherapy and Psychosomatics 71 6 (2002) 318-325
14. Jacobson N.S., and Truax P. Clinical-significance - a statistical approach to defining meaningful change in psychotherapy-research. Journal of Consulting and Clinical Psychology 59 1 (1991) 12-19
15. Kellner R. Prognosis of treated hypochondriasis: a clinical study. Acta Psychiatrica Scandinavica 67 2 (1983) 69-79
16. Noyes R.J.R., Kathol R.G., Fisher M.M., Phillips B.M., Suelzer M.T., and Holt C.S. The validity of DSM-III-R hypochondriasis. Archives of General Psychiatry 12 (1993) 961-970
17. Oosterbaan D.B., van Balkom A.J.L.M., van Boeijen C.A., de Meij T.G.J., and van Dyck R. An open study of paroxetine in hypochondriasis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 25 5 (2001) 1023-1033
18. Pilowsky I. Dimensions of hypochondriasis. British Journal of Psychiatry 113 494 (1967) 89-93
19. Rasbash J., Brown W., Goldstein H., Yang M., Plewis I., Healy M., et al. A user's guide to MLwiN (2002), Centre for Multilevel Modelling, Institute of Education, University of London, London
20. Speckens A.E.M., Spinhoven P., Sloekers P.P.A., and Bolk J.H. A validation study of the Whitely index, the illness attitude scales, and the somatosensory amplification scale in general medical and general practice patients. Journal of Psychosomatic Research 40 1 (1996) 95-104
21. van Oppen P., van Balkom A.J.L.M., de Haan E., and van Dyck R. Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up. Journal of Clinical Psychiatry 66 11 (2006) 1415-1422
22. Visser S., and Bouman T.K. The treatment of hypochondriasis: exposure plus response prevention vs cognitive therapy. Behaviour Research and Therapy 39 4 (2001) 423-442
23. Warwick H.M.C., Clark D.M., Cobb A.M., and Salkovskis P.M. A controlled trail of cognitive-behavioural treatment of hypochondriasis. British Journal of Psychiatry 169 2 (1996) 189-195
24. Westen D., and Morrison K. A multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. Journal of Consulting and Clinical Psychology 69 6 (2001) 875-899